Dowell Bio
Dowell Bio
Fast axonal fusion
from lab to surgery
We contribute to methods of spinal cord and peripheral nerve conduction
using advanced fusogens and surgical delivery
Supported by
Spinal and peripheral nerve injuries steal motion and sensation. Current care waits months for slow axonal regrowth or accepts permanent loss of function.
We're contributing to the protocol, hardware, and clinical practice for immediate reconnection — a conduction bridge for the spinal cord and peripheral nerves fused in hours.
Programs
Optimized studies, ready for multi-centered reproduction. Research requires a full cycle - from chemical synthesis and cell culture studies to experimental operations and histological research.
Spinal Cord Fusion
Active preclinical work in rodents; pilot in swine showed recovery of motor function; now optimizing formulation for intra-op use and planning a delivery device on swine.
Peripheral Nerve Rapid Fusion
Protocol ready (site, docs, budget). Designed to bypass Wallerian-dependent delays via membrane fusion. Prepared to launch.
Evidence
Initial studies were done in Moscow, Russia by Dr. Michael Lebenstein-Gumovski, who is continuing his research and is also now the scientific expert of the project.
We are reproducing the studies in Mexico and Vietnam to establish the protocols before pilot clinical studies.
Neuro-PEG induced restoration of motor function after complete transection of the dorsal spinal cord in swine. A pilot study.
Surgical Neurology International, 2023
Neuro-PEG-mediated spinal cord fusion after complete dorsal transection in rabbits – functional results at 30 days.
Surgical Neurology International, 2023
A phrenic-sparing cephalic reanastomosis model: Acute effects and implications.
bioRxiv preprint, 2025
Ethics & Compliance
Approved protocols, humane endpoints, full documentation. The clinical path prioritizes safety, transparent reporting, and jurisdiction-specific oversight.
We do not market therapies; we document research.
Team
Andrei Panferov
Chief Executive Officer
Experienced tech entrepreneur with 17 years in the industry.
Previously founded TalentRiver, a fast-growing AI company in HRTech based in Stockholm.
Expert in product development, strategy, fundraising, and go-to-market execution.
Dr. Michael Lebenstein-Gumovski
Scientific Expert
PhD in Neurosurgery
Senior Scientific Officer, Neurosurgeon at Neurosurgery Department at Sklifosovsky Clinical and Research Institute for Emergency Medicine
Since 2013 was studying spinal cord injury, and also developing methods for restoring the functional and morphological reparation of the spinal cord in an experiment.
Contact
Get in Touch
Email us directly
andrei@dowell.bioReady to partner with us or learn more about our breakthrough axonal fusion technology? We'd love to hear from you.
Partnership
Materials available
Strategic
Request materials or propose a joint study.